SALT LAKE CITY — Schiff Nutrition International on Wednesday named Shane Durkee SVP research and development.
“We welcome Shane and believe his proven track record in driving nutritional supplements innovation will contribute significantly to accelerating our new product program and organic growth," Schiff president and CEO Tarang Amin said.
Durkee, 39, has more than 16 years of consumer products research and development experience in leading teams in innovation, product development and medical science. Most recently, he was the director, global innovation and new technology at Bayer Consumer Care in Basel, Switzerland. In this position, he led product innovation and development within the nutritional, dermatologic and gastrointestinal business units, which had more than $2.7 billion in annual sales. He also served in R&D leadership roles working on Bayer’s U.S. branded nutritional business, including One-A-Day, Flintstones and CitraCal. Prior to joining Bayer, Durkee held R&D leadership roles with TwinLab and Nutraceutical Corp.
Durkee holds a B.S. in Microbiology and an M.B.A. He has served as a member of the Senior Scientific Advisory Council for the Council for Responsible Nutrition and as a science advisory board member at Virgo Publishing.